000 | 01983 a2200589 4500 | ||
---|---|---|---|
005 | 20250516060322.0 | ||
264 | 0 | _c20120209 | |
008 | 201202s 0 0 eng d | ||
022 | _a1472-6750 | ||
024 | 7 |
_a10.1186/1472-6750-11-90 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOtvos, Laszlo | |
245 | 0 | 0 |
_aDesign and development of a peptide-based adiponectin receptor agonist for cancer treatment. _h[electronic resource] |
260 |
_bBMC biotechnology _cOct 2011 |
||
300 |
_a90 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 |
_aAdiponectin _xchemistry |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Intraperitoneal |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, SCID |
650 | 0 | 4 | _aMolecular Dynamics Simulation |
650 | 0 | 4 |
_aObesity _xdrug therapy |
650 | 0 | 4 |
_aOligopeptides _xchemistry |
650 | 0 | 4 |
_aPeptidomimetics _xchemistry |
650 | 0 | 4 | _aProtein Array Analysis |
650 | 0 | 4 |
_aRNA, Small Interfering _xmetabolism |
650 | 0 | 4 |
_aReceptors, Adiponectin _xagonists |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 |
_aTumor Burden _xdrug effects |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aHaspinger, Eva | |
700 | 1 | _aLa Russa, Francesca | |
700 | 1 | _aMaspero, Federica | |
700 | 1 | _aGraziano, Patrizia | |
700 | 1 | _aKovalszky, Ilona | |
700 | 1 | _aLovas, Sandor | |
700 | 1 | _aNama, Kaushik | |
700 | 1 | _aHoffmann, Ralf | |
700 | 1 | _aKnappe, Daniel | |
700 | 1 | _aCassone, Marco | |
700 | 1 | _aWade, John | |
700 | 1 | _aSurmacz, Eva | |
773 | 0 |
_tBMC biotechnology _gvol. 11 _gp. 90 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1472-6750-11-90 _zAvailable from publisher's website |
999 |
_c21209738 _d21209738 |